General anaesthesia in children carries a risk of pulmonary aspiration of gastric contents [1] ; the incidence is higher than in adults [2, 3] . The severity of lung damage after gastric fluid aspiration is determined often by the pH and volume of the fluid aspirated [4, 5] . Many investigators have shown that a high percentage of paediatric patients who come to the operating room have a gastric fluid volume > 0.4 ml kg" 1 and pH < 2.5, regardless of the fasting interval [6] [7] [8] [9] [10] . Patients who fulfil these criteria are believed to be at increased risk of developing aspiration pneumonitis [11, 12] . Several pharmacological attempts have been made successfully to reduce the risk of lung damage by decreasing gastric acid secretion in paediatric surgery [1, 9, 10, [13] [14] [15] [16] [17] . Histamine H 2 receptor antagonists, including cimetidine, ranitidine and famotidine, have been advocated for use in the preoperative period to modify gastric contents before induction of paediatric anaesthesia [9, 10, [13] [14] [15] [16] [17] .
Nizatidine is a new, potent H 2 receptor antagonist [18, 19] . The drug has been used orally in the treatment of peptic ulceration and reflux oesophagitis [20] [21] [22] [23] . The use of nizatidine as effective premedication to increase gastric fluid pH and decrease volume has been reported in adults undergoing gynaecological laparoscopy [24] . We have conducted a controlled, randomized, prospective study to evaluate the efficacy of preoperative oral nizatidine 6 mg kg" 1 in total, in controlling gastric fluid pH and volume in children. To make diis assessment, we used three different timings of administration of the drug: at bedtime before surgery, on the morning of the day of surgery and a combination of the two timings. Table 1 shows the patient profiles. We used Acinon capsule, which contains 150 mg of nizatidine and the dose was taken with a syrup. Milk and solids were allowed until 21:00 before surgery. Patients were instructed to ingest a large volume of apple juice (10 ml kg" 1 ) 3 h before induction of anaesthesia (at 05:30 on the day of surgery). Although most of the children followed this instruction, some patients were hesitant about ingesting up to 10 ml kg' 1 or ingested a little more than 10 ml kg" 1 . However, all children ingested a large volume (table 1) . Ingestion of a large volume of clear fluid is the usual regimen for paediatric anaesthesia in our hospital [25] [26] [27] . Splinter, Stewart and Muir used a large volume of liquid similar to that in our study [28] . Berry recommended 10 ml kg"' of clear fluids as the last preoperative oral intake [29] .
Induction of anaesthesia in all patients was started at 08:30. After preoxygenation with 100% oxygen by mask, anaesthesia was induced with nitrous oxide 4 litre min" 1 , oxygen 2 litre min" 1 and gradually increasing concentrations of halothane up to 1.5%. Infusion started immediately after we confirmed loss of consciousness. Atropine 0.01 mg kg" 1 was then given i.v. and the concentration of halothane was increased to 2.5%. This form of anaesthetic induction, which is similar to that described by Motoyama [30] , is routine for paediatric anaesthesia in our hospital [25] to avoid fear and pain caused by needles in children. The lungs were ventilated carefully to avoid inflation of the stomach. Tracheal intubation was facilitated with vecuronium 0.1 mgkg" 1 i.v. All inductions were uneventful and no patient experienced coughing, laryngospasm or vomiting during induction.
After tracheal intubation, a 16-French gauge Argyle Salem Sump catheter was inserted into the stomach, and its position verified by auscultation over the epigastrium during introduction of 5-10 ml of air. Gastric fluid samples were obtained by gentle aspiration with a 50-ml syringe. Aspirations were attempted with the child in the supine, reverse Trendelenburg and in both lateral decubirus positions to maximize gastric emptying. The researcher performing the aspiration was unaware of the patient's preanaesthetic medication. Gastric contents were inspected visually for particles and the volume of gastric contents was measured with the syringe. Pressure was applied over the epigastrium with the patient supine and then in the left and right lateral decubitus positions to ensure maximum emptying of gastric fluid. The pH of the gastric fluid was measured immediately by an independent observer using a pH meter (Horiba F-8L, Japan), which has a precision of 0.01 pH units over the entire pH range. The electrode was calibrated using standard buffers at pH values of 4, 7 and 9.
Age, weight, volume of apple juice ingested, and gastric fluid pH and volume were recorded for each patient.
Comparisons of data between groups were made using one-way analysis of variance and Bonferroni correction for multiple comparisons of parameteric data, while the Kruskal-Wallis rank test was used for non-parametric data. Chi-square test was used for proportions of patients at risk of developing pulmonary acid aspiration syndrome. P < 0.05 was considered statistically significant.
Twenty-six patients in each group were necessary to detect changes in gastric volume and pH between groups at a significance level of 0.05, although the power of the study was relatively weak (1 -P = 0.8, where P = probability of type II error) [31] .
Results
There were no significant differences between the four groups in age, weight or volume of fluids ingested (table 1) .
Although gastric fluid was obtained from all children, the volume was sufficient for pH determination in only 81 of the 104 samples. In the remainder, an insufficient quantity of gastric aspirate precluded measurement; these small quantities of gastric fluid were assigned a residual volume of 0 ml. Gastric fluid volume was greater in the control and nizatidine-placebo groups than with the other two regimens ( fig. 1) . The placebo-nizatidine and nizatidine-nizatidine groups had similar gastric volumes. It is noteworthy that these groups had a gastric volume of almost 0.4 ml kg" 1 , that is near the cut-off value for risk of aspiration pneumonitis. These two groups had a higher gastric fluid pH than did the control and nizatidine-placebo groups, in which gastric pH was similar ( fig. 1) . The placebo-placebo and nizatidine-placebo groups had similar proportions of high risk patients (46 % and 38%, respectively). The risk was decreased in the placebo-nizatidine (4%) and nizatidinenizatidine (0%) groups.
No children had paniculate matter in gastric aspirates. No adverse effects (skin rash, headache or diarrhoea) considered to be related to nizatidine were observed.
Discussion
Acid aspiration prophylaxis before surgery is generally believed to be unnecessary in healthy children presenting for surgery [1] , However, its use might be considered in patients where airway difficulties are anticipated [1] . Children with trauma may be another group of patients who may benefit because these patients are likely to have delayed gastric emptying, and even prolonged fasts will not be helpful in all patients [32] . H 2 antagonists have been studied as acid aspiration prophylaxis in otherwise healthy children presenting for routine surgery. Cimetidine [14] , famotidine [13] and ranitidine [17] have been shown to increase the pH of gastric fluid. However, to the best of our knowledge, the use of nizatidine as premedication in children has not been reported. In the present study, we used ASA I children. This population was chosen to ensure a safe approach to the initial evaluation of the effects of nizatidine.
Consistent with a previous report in adults [24] , we have shown in children that preoperative nizatidine effectively increased gastric pH and decreased gastric volume. As reduction in gastric volume is not a consistent feature in studies of H 2 antagonists [13, 14, 17] , the ability of nizatidine to decrease gastric volume may be an advantage over other H 2 antagonists. However, mean gastric volume in children receiving nizatidine remained at 0.4 ml kg" 1 , the cutoff value for risk of aspiration pneumonia [1] . Thus the effectiveness of nizatidine as premedication is probably mainly as a result of an increase in gastric pH rather than a decrease in gastric volume. Nizatidine is a highly selective H 2 receptor blocking drug which is as potent as ranitidine and is characterized by high bioavailability (71 %) compared with ranitidine (50 %) and a short time to peak plasma concentrations (within 2 h) after an oral dose [18, 33] . Rebound increases in gastric secretion after discontinuation of nizatidine seem to occur less frequently than with ranitidine [34] . Nizatidine does not interfere with drug metabolism by binding to cytochrome P450 [35] and it does not influence male or female hormone function, or fertility [18, 36, 37] . Unlike cimetidine, no interactions have been observed in humans with warfarin [38] , lignocaine [39] , diazepam [35] , chlordiazepoxide [40] , lorazepam [40] , metoprolol [41] or theophylline [40] . Nizatidine has no effect on secretion of gastric mucus [42] . These characteristics may be advantageous.
The rationale for using nizatidine 6 mg kg" 1 as a total dose in the present study was based on the following data from other laboratories and our preliminary studies. Nizatidine has an accepted place in clinical practice for treatment of reflux oesophagitis and peptic ulcer [20] [21] [22] [23] . For this purpose, oral administration of nizatidine 300 mg day • (equivalent to 6 mg kg" 1 for 50-kg adults) is advocated in adults [20] [21] [22] [23] . No major adverse effects were observed in these reports. However, the dose used in the present study may have been inappropriate because of different morphological and pharmacokinetic factors from those in adults; further studies are therefore needed to establish the dose-response relationship of nizatidine.
The timing of administration of nizatidine (2 h before anaesthesia in the placebo-nizatidine and nizatidine-nizatidine groups) was chosen because the tC e max of nizatidine is 1-2 h after oral administration of 150-300 mg [18, 43] and the onset of the gastric antisecretory effect of nizatidine is obvious within 0.5-1 h after a single oral dose of 300 mg [44] [45] [46] [47] [48] . This onset is more rapid than other H 2 antagonists. Compared with other H 2 blockers, nizatidine has a shorter duration of antisecretory effect (approximately 8h after 150 mg or 300 mg) [47, 48] . This pharmacokinetic characteristic may be responsible for our observations that a single dose of oral nizatidine 6 mg kg" 1 on the morning of surgery could reduce the number of children considered at risk of aspiration pneumonitis although the same dose at bedtime before surgery failed to increase gastric pH and decrease gastric volume: the night dose may be ineffective and superfluous. The results in the nizatidine-nizatidine group suggest that 3 mg kg" 1 in the morning is as effective as die larger dose (placebo-nizatidine 6 mg kg" 1 ). Blind aspiration, as used in the present study, is a common method of measuring volume of gastric contents [49] [50] [51] . Although constant manual aspiration with a syringe consistently yields greater recovery of gastric fluid than techniques that use wall suction or intermittent aspiration [52] , it does not completely empty the stomach which therefore results in underestimation of gastric fluid volume [53] . In addition, both the functional division of die stomach into antral and fundal sacs [54] and the physical characteristics of the orogastric tube [52] may interfere with the accuracy of blind aspiration. To minimize these errors, we aspirated manually via a large-bore, multi-orifice orogastric tube which was repositioned several times with the patient in first the supine and reverse Trendelenburg positions and dien in the left and right lateral decubitus positions.
The rate of gastric emptying depends on several variables, including volume of ingested fluids [55] . As a large volume of ingested clear fluid increases gastric pressure more than a small volume, and a greater intragastric pressure results in greater gastric emptying [56] , it is evident that a large volume would result in greater gastric emptying. Thus the children in the present study were required to ingest a large volume of apple juice (approximately 10 ml kg" 1 ) during the fasting period to increase the rate of gastric emptying.
In conclusion, we have shown that oral nizatidine 6 mg kg" 1 administered on the morning of surgery or 3 mg kg" 1 at bedtime and the same dose on the morning of surgery, increased preoperative gastric fluid pH and decreased gastric volume in children and thereby reduced the number of children considered at risk for aspiration pneumonitis. Oral nizatidine may be useful in children undergoing surgery who have airway difficulties which are considered to increase the risk of aspiration pneumonitis. Further studies are required to evaluate the effectiveness of the drug in these paediatric patients, and the optimal dose, timing and safety of die drug in children.
